Skip to content

Clinical trials

COVID-19 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: South Korea Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
202027
202126
20229
20237
20245
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Unknown status12
Terminated10
Recruiting7
Active, not recruiting6
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer9
Cellid Co., Ltd.5
National Institute of Allergy and Infectious Diseases (NIAID)5
Daewoong Pharmaceutical Co. LTD.4
Korea University Guro Hospital4
SK Bioscience Co., Ltd.4
Celltrion3
Gilead Sciences3
Seoul National University Hospital3
Shin Poong Pharmaceutical Co. Ltd.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1984
Coronavirus Infections8
Virus Diseases6
Infections5
Influenza, Human5
Pneumonia4
Lung Diseases3
Respiratory Tract Infections3
Pneumonia, Viral2
RNA Virus Infections2

Trials

Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.